SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-14-390414
Filing Date
2014-10-31
Accepted
2014-10-30 21:46:02
Documents
9

Document Format Files

Seq Description Document Type Size
1 425 d813578d425.htm 425 42178
2 GRAPHIC g813578g36m63.jpg GRAPHIC 105073
3 GRAPHIC g813578g66n18.jpg GRAPHIC 312041
4 GRAPHIC g813578g70i80.jpg GRAPHIC 317659
5 GRAPHIC g813578g71w21.jpg GRAPHIC 348486
6 GRAPHIC g813578g76j80.jpg GRAPHIC 190972
7 GRAPHIC g813578g90e68.jpg GRAPHIC 282246
8 GRAPHIC g813578g97e50.jpg GRAPHIC 343572
9 GRAPHIC g813578g99z48.jpg GRAPHIC 320812
  Complete submission text file 0001193125-14-390414.txt   3104967
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-14956 | Film No.: 141184652
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425